Skip to main content
. 2018 Aug 31;7(10):5107–5117. doi: 10.1002/cam4.1753

Figure 1.

Figure 1

The proportion of low‐risk (BCR‐ABL1 ≤40%) and high‐risk (BCR‐ABL1 >40%) patients according to VEMR achievement at 4 wk